ImageneBio annual total assets
2020
2021
2022
2023
2024
2025
ImageneBio Total Assets Growth & History (IMA)
ImageneBio's total assets was $153.0M for fiscal 2025.
View full ImageneBio company overviewImageneBio annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $153.0M | $137.1M | +860.78% |
| 2024 | 2024-12-31 | $15.9M | −$176.2M | −91.71% |
| 2023 | 2023-12-31 | $192.1M | $19.8M | +11.51% |
| 2022 | 2022-12-31 | $172.3M | −$75.6M | −30.51% |
| 2021 | 2021-12-31 | $247.9M | $79.5M | +47.19% |
| 2020 | 2020-12-31 | $168.4M | — | — |
ImageneBio quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $152.0M | $25.9M | +20.51% |
| Q1 2026 | 2026-03-31 | $136.7M | $5.8M | +4.47% |
| Q4 2025 | 2025-12-31 | $153.0M | $137.1M | +860.78% |
| Q3 2025 | 2025-09-30 | $160.9M | $11.9M | +7.98% |
| Q2 2025 | 2025-06-30 | $126.2M | −$31.3M | −19.89% |
| Q1 2025 | 2025-03-31 | $130.8M | −$41.9M | −24.28% |
| Q4 2024 | 2024-12-31 | $15.9M | −$176.2M | −91.71% |
| Q3 2024 | 2024-09-30 | $149.0M | −$66.3M | −30.81% |
| Q2 2024 | 2024-06-30 | $157.5M | −$14.3M | −8.31% |
| Q1 2024 | 2024-03-31 | $172.8M | $20.4M | +13.37% |
| Q4 2023 | 2023-12-31 | $192.1M | $19.8M | +11.51% |
| Q3 2023 | 2023-09-30 | $215.3M | $24.9M | +13.06% |
| Q2 2023 | 2023-06-30 | $171.8M | −$39.4M | −18.67% |
| Q1 2023 | 2023-03-31 | $152.4M | −$75.3M | −33.08% |
| Q4 2022 | 2022-12-31 | $172.3M | −$75.6M | −30.51% |
| Q3 2022 | 2022-09-30 | $190.5M | −$71.2M | −27.22% |
| Q2 2022 | 2022-06-30 | $211.2M | −$67.6M | −24.26% |
| Q1 2022 | 2022-03-31 | $227.7M | −$65.9M | −22.45% |
| Q4 2021 | 2021-12-31 | $247.9M | $79.5M | +47.19% |
| Q3 2021 | 2021-09-30 | $261.7M | — | — |
| Q2 2021 | 2021-06-30 | $278.8M | — | — |
| Q1 2021 | 2021-03-31 | $293.7M | — | — |
| Q4 2020 | 2020-12-31 | $168.4M | — | — |
ImageneBio total assets trends
Over the last five fiscal years, ImageneBio's total assets decreased from $168.4M to $153.0M, a change of −$15.4M. The latest reported quarter, Q2 2026, shows $152.0M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ImageneBio source filings ↗